Keywords
Last Name
Institution

Peter C Albertsen MD

AddressMC 3955
MC 3955
263 Farmington Avenue
Phone860-699-3195
Fax860-679-1064
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Albertsen has obtained an international reputation for his work on prostate cancer and is the author of numerous publications. He is on the editorial board of several journals and frequently reviews manuscripts for the major urological journals. Furthermore, he holds the prestigious honor of being a trustee of the American Board of Urology as well as a member of the Residency Review Committee of ACGME for Urology. He is a member of the American Urological Association, American Association of Genitourinary Surgeons and the Society of Urologic Oncology among others.

    Dr. Albertsen is a graduate of Princeton University and earned his medical degree from Columbia University College of Physicians and Surgeons in 1978. After two years of surgical training at Harvard’s Deaconess Hospital in Boston he completed his residency training in urology at the Johns Hopkins University Brady Urological Institute in 1984. He subsequently received an M.S. in medical administration and preventative medicine from University of Wisconsin in 1990.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Turner EL, Metcalfe C, Donovan JL, Noble S, Sterne JA, Lane JA, I Walsh E, Hill EM, Down L, Ben-Shlomo Y, Oliver SE, Evans S, Brindle P, Williams NJ, Hughes LJ, Davies CF, Ng SY, Neal DE, Hamdy FC, Albertsen P, Reid CM, Oxley J, McFarlane J, Robinson MC, Adolfsson J, Zietman A, Baum M, Koupparis A, Martin RM. Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee. Br J Cancer. 2016 Jun 28; 115(1):90-4. PMID: 27253172.
      View in: PubMed
    2. Barry MJ, Albertsen PC. Is Prostate-Specific Antigen Screening "Proven Ineffective Care"? Ann Intern Med. 2016 May 17; 164(10):687-8. PMID: 26902323.
      View in: PubMed
    3. Welch HG, Gorski DH, Albertsen PC. Trends in Metastatic Breast and Prostate Cancer. N Engl J Med. 2016 Feb 11; 374(6):596. PMID: 26863368.
      View in: PubMed
    4. Kent M, Penson DF, Albertsen PC, Goodman M, Hamilton AS, Stanford JL, Stroup AM, Ehdaie B, Scardino PT, Vickers AJ. Successful external validation of a model to predict other cause mortality in localized prostate cancer. BMC Med. 2016; 14(1):25. PMID: 26860993.
      View in: PubMed
    5. Albertsen PC, Lu-Yao GL. Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Grace L. Lu-Yao, Peter C. Albertsen, Dirk F. Moore, Yong Lin, Robert S. DiPaola, Siu-Long Yao. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer. Eur Urol 2015;68:805-11. Eur Urol. 2016 Jun; 69(6):e131-2. PMID: 26706104.
      View in: PubMed
    6. Albertsen PC. Surgery is possible: now let's prove its superior efficacy! BJU Int. 2015 Dec; 116(6):834-5. PMID: 26542323.
      View in: PubMed
    7. Carlsson S, Leapman M, Carroll P, Schröder F, Albertsen PC, Ilic D, Barry M, Frosch DL, Vickers A. Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Med. 2015; 13:288. PMID: 26612204; PMCID: PMC4662021.
    8. Bourke L, Smith D, Steed L, Hooper R, Carter A, Catto J, Albertsen PC, Tombal B, Payne HA, Rosario DJ. Exercise for Men with Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 2016 Apr; 69(4):693-703. PMID: 26632144.
      View in: PubMed
    9. Albertsen PC. Does a positive margin always mandate adjuvant radiotherapy? BJU Int. 2015 Nov; 116(5):677-8. PMID: 26449168.
      View in: PubMed
    10. Welch HG, Gorski DH, Albertsen PC. Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics. N Engl J Med. 2015 Oct 29; 373(18):1685-7. PMID: 26510017.
      View in: PubMed
    11. Albertsen PC. Another Reason to Consider Active Surveillance. Eur Urol. 2016 Apr; 69(4):582-3. PMID: 26603782.
      View in: PubMed
    12. O'Neil B, Koyama T, Alvarez J, Conwill RM, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, Stanford JL, Stroup AM, Paddock LE, Wu XC, Stephenson RA, Resnick MJ, Barocas DA, Penson DF. The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples. J Urol. 2016 Feb; 195(2):321-9. PMID: 26343985.
      View in: PubMed
    13. Albertsen PC. Observational studies and the natural history of screen-detected prostate cancer. Curr Opin Urol. 2015 May; 25(3):232-7. PMID: 25692723.
      View in: PubMed
    14. Lu-Yao GL, Albertsen PC, Moore DF, Lin Y, DiPaola RS, Yao SL. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer. Eur Urol. 2015 Nov; 68(5):805-11. PMID: 25800944; PMCID: PMC4575827 [Available on 11/01/16].
    15. Hoffman RM, Koyama T, Albertsen PC, Barry MJ, Daskivich TJ, Goodman M, Hamilton AS, Stanford JL, Stroup AM, Potosky AL, Penson DF. Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study. J Gen Intern Med. 2015 Jul; 30(7):924-34. PMID: 25678374; PMCID: PMC4471031 [Available on 07/01/16].
    16. Albertsen PC. Prostate-specific antigen testing: good or bad? Oncologist. 2015 Mar; 20(3):233-5. PMID: 25673105; PMCID: PMC4350812.
    17. Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Lawrence W, Miller A, ProroK PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P. Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Rev Recent Clin Trials. 2015; 10(3):206-11. PMID: 26238119.
      View in: PubMed
    18. Albertsen PC. Words of wisdom. Re: Radical prostatectomy or watchful waiting in early prostate cancer. Eur Urol. 2014 Dec; 66(6):1187. PMID: 25587591.
      View in: PubMed
    19. Carter HB, Albertsen PC. Re: Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening. J Urol. 2015 Mar; 193(3):1063-4; discussion 1064. PMID: 25476113.
      View in: PubMed
    20. Morgans AK, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Resnick MJ, Barocas DA, Penson DF. Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy. J Urol. 2015 Apr; 193(4):1226-31. PMID: 25451829; PMCID: PMC4542148 [Available on 04/01/16].
    21. Carlsson SV, Albertsen PC. Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Eur Urol. 2015 Aug; 68(2):183-4; discussion 184-5. PMID: 25466944.
      View in: PubMed
    22. Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Litwin MS, Penson DF. Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study. Urology. 2015 Jan; 85(1):92-100. PMID: 25261048; PMCID: PMC4275422 [Available on 01/01/16].
    23. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Yao SL. Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer. JAMA Intern Med. 2014 Sep; 174(9):1460-7. PMID: 25023796.
      View in: PubMed
    24. Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Koyama T, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, McCollum D, Paddock LE, Stanford JL, Stroup AM, Wu XC, Penson DF. The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Eur Urol. 2015 Jun; 67(6):1019-25. PMID: 25174325; PMCID: PMC4412750 [Available on 06/01/16].
    25. Morgans AK, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Penson DF. Bone complications among prostate cancer survivors: long-term follow-up from the prostate cancer outcomes study. Prostate Cancer Prostatic Dis. 2014 Dec; 17(4):338-42. PMID: 25134939; PMCID: PMC4227957.
    26. Albertsen P. Radical prostatectomy reduces prostate cancer-specific mortality among men with intermediate-grade disease, but provides minimal benefit for men with low-grade and high-grade disease. Evid Based Med. 2014 Oct; 19(5):176. PMID: 24919977.
      View in: PubMed
    27. Jarow JP, Thompson IM, Kluetz PG, Baxley J, Sridhara R, Scardino P, Carroll P, Albertsen P, Carter HB, Brawley O, Sartor O, Sandler H, Kiefert JJ, Morton RA. Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop. Urology. 2014 May; 83(5):975-8. PMID: 24661332.
      View in: PubMed
    28. Albertsen PC. Times, they are a-changing. Eur Urol. 2014 Sep; 66(3):428-9. PMID: 24332346.
      View in: PubMed
    29. Albertsen PC, Klotz L, Tombal B, Grady J, Olesen TK, Nilsson J. Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist. Eur Urol. 2014 Mar; 65(3):565-73. PMID: 24210090.
      View in: PubMed
    30. Albertsen PC. Words of wisdom: Re: Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Eur Urol. 2013 Sep; 64(3):512. PMID: 23915461.
      View in: PubMed
    31. Albertsen PC, Marks LS. MRI before prostate biopsy--yes or no? J Urol. 2013 Dec; 190(6):1978-80. PMID: 23994537.
      View in: PubMed
    32. Valicenti RK, Thompson I, Albertsen P, Davis BJ, Goldenberg SL, Wolf JS, Sartor O, Klein E, Hahn C, Michalski J, Roach M, Faraday MM. Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. Int J Radiat Oncol Biol Phys. 2013 Aug 1; 86(5):822-8. PMID: 23845839.
      View in: PubMed
    33. Daskivich TJ, Fan KH, Koyama T, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Stanford JL, Stroup AM, Litwin MS, Penson DF. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med. 2013 May 21; 158(10):709-17. PMID: 23689764; PMCID: PMC3760479.
    34. Thompson IM, Valicenti RK, Albertsen P, Davis BJ, Goldenberg SL, Hahn C, Klein E, Michalski J, Roach M, Sartor O, Wolf JS, Faraday MM. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. J Urol. 2013 Aug; 190(2):441-9. PMID: 23707439.
      View in: PubMed
    35. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL. Early detection of prostate cancer: AUA Guideline. J Urol. 2013 Aug; 190(2):419-26. PMID: 23659877; PMCID: PMC4020420.
    36. Hoffman RM, Koyama T, Fan KH, Albertsen PC, Barry MJ, Goodman M, Hamilton AS, Potosky AL, Stanford JL, Stroup AM, Penson DF. Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. J Natl Cancer Inst. 2013 May 15; 105(10):711-8. PMID: 23615689; PMCID: PMC3653822.
    37. Noon AP, Albertsen PC, Thomas F, Rosario DJ, Catto JW. Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer. 2013 Apr 16; 108(7):1534-40. PMID: 23481180; PMCID: PMC3629420.
    38. van den Bergh RC, Albertsen PC, Bangma CH, Freedland SJ, Graefen M, Vickers A, van der Poel HG. Timing of curative treatment for prostate cancer: a systematic review. Eur Urol. 2013 Aug; 64(2):204-15. PMID: 23453419; PMCID: PMC3784981.
    39. Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013 Jan 31; 368(5):436-45. PMID: 23363497; PMCID: PMC3742365.
    40. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Prostate specific antigen best practice statement: 2009 update. J Urol. 2013 Jan; 189(1 Suppl):S2-S11. PMID: 23234625.
      View in: PubMed
    41. Albertsen PC. What is the risk posed by prostate cancer? J Natl Cancer Inst Monogr. 2012 Dec; 2012(45):169-74. PMID: 23271769; PMCID: PMC3540873.
    42. Albertsen PC. Editorial comment: Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme. BJU Int. 2012 Dec; 110(11):1653. PMID: 22984891.
      View in: PubMed
    43. Studer UE, Albertsen PC. It's time to change the treatment paradigm for prostate cancer! Eur Urol. 2013 Jan; 63(1):97-9; discussion 99-100. PMID: 22959353.
      View in: PubMed
    44. Albertsen PC. Editorial comment. Urology. 2012 Oct; 80(4):888. PMID: 22921701.
      View in: PubMed
    45. Albertsen P. The prostate cancer conundrum revisited: further insights. Cancer. 2012 Dec 1; 118(23):5724-7. PMID: 22736235.
      View in: PubMed
    46. Albertsen PC. Robot-assisted radical prostatectomy - fake innovation or the real deal? Eur Urol. 2012 Sep; 62(3):365-7. PMID: 22705383.
      View in: PubMed
    47. Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol. 2012 Dec; 62(6):976-83. PMID: 22698574.
      View in: PubMed
    48. Lu-Yao GL, Albertsen PC, Li H, Moore DF, Shih W, Lin Y, DiPaola RS, Yao SL. Does primary androgen-deprivation therapy delay the receipt of secondary cancer therapy for localized prostate cancer? Eur Urol. 2012 Dec; 62(6):966-72. PMID: 22608160; PMCID: PMC3472155.
    49. Makarov DV, Desai R, Yu JB, Sharma R, Abraham N, Albertsen PC, Krumholz HM, Penson DF, Gross CP. Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat. Health Aff (Millwood). 2012 Apr; 31(4):730-40. PMID: 22492890.
      View in: PubMed
    50. Albertsen PC. How best to use our tools? Eur Urol. 2012 Aug; 62(2):201-2; discussion 203. PMID: 22386191.
      View in: PubMed
    51. Messing EM, Albertsen P, Andriole GL, Carroll PR, Klein EA. The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing. Urol Oncol. 2012 Jan-Feb; 30(1):117-9. PMID: 22243597.
      View in: PubMed
    52. Bourke L, Chico TJ, Albertsen PC, Hamdy FC, Rosario DJ. Cardiovascular risk in androgen suppression: underappreciated, under-researched and unresolved. Heart. 2012 Mar; 98(5):345-8. PMID: 22155645.
      View in: PubMed
    53. Zhu X, Albertsen PC, Andriole GL, Roobol MJ, Schröder FH, Vickers AJ. Risk-based prostate cancer screening. Eur Urol. 2012 Apr; 61(4):652-61. PMID: 22134009.
      View in: PubMed
    54. Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Penson DF, Gross CP. The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population. J Urol. 2012 Jan; 187(1):97-102. PMID: 22088337.
      View in: PubMed
    55. Albertsen P. A tale of 2 perspectives: the clinician and the public health professional. Cancer. 2012 Jun 15; 118(12):3010-1. PMID: 22006679.
      View in: PubMed
    56. Catto JW, Robinson MC, Albertsen PC, Goepel JR, Abbod MF, Linkens DA, Davis M, Rosario DJ, Warren AY, Varma M, Griffiths DF, Grigor KM, Mayer NJ, Oxley JD, Deshmukh NS, Lane JA, Metcalfe C, Donovan JL, Neal DE, Hamdy FC. Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study. Br J Cancer. 2011 Sep 27; 105(7):931-7. PMID: 21863028; PMCID: PMC3185935.
    57. Ginzburg S, Albertsen PC. The timing and extent of androgen deprivation therapy for prostate cancer: weighing the clinical evidence. Endocrinol Metab Clin North Am. 2011 Sep; 40(3):615-23, ix. PMID: 21889724.
      View in: PubMed
    58. Shao YH, Albertsen PC, Shih W, Roberts CB, Lu-Yao GL. The impact of PSA testing frequency on prostate cancer incidence and treatment in older men. Prostate Cancer Prostatic Dis. 2011 Dec; 14(4):332-9. PMID: 21709691; PMCID: PMC3649843.
    59. Albertsen PC. When is active surveillance the appropriate treatment for prostate cancer? Acta Oncol. 2011 Jun; 50 Suppl 1:120-6. PMID: 21604952.
      View in: PubMed
    60. Albertsen P. Words of wisdom. Re: active surveillance compared with initial treatment in men with low-risk prostate cancer: a decision analysis. Eur Urol. 2011 May; 59(5):882-3. PMID: 21524728.
      View in: PubMed
    61. Roberts CB, Albertsen PC, Shao YH, Moore DF, Mehta AR, Stein MN, Lu-Yao GL. Patterns and correlates of prostate cancer treatment in older men. Am J Med. 2011 Mar; 124(3):235-43. PMID: 21396507.
      View in: PubMed
    62. Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol. 2011 Apr 1; 29(10):1335-41. PMID: 21357791; PMCID: PMC3084001.
    63. Gjertson CK, Albertsen PC. Use and assessment of PSA in prostate cancer. Med Clin North Am. 2011 Jan; 95(1):191-200. PMID: 21095422.
      View in: PubMed
    64. Albertsen PC. WHO International Consultation on Prostate Cancer: a summary. Acta Oncol. 2011 Jun; 50 Suppl 1:155-60. PMID: 21166604.
      View in: PubMed
    65. Thong MS, van de Poll-Franse L, Hoffman RM, Albertsen PC, Hamilton AS, Stanford JL, Penson DF. Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. BJU Int. 2011 Apr; 107(8):1223-31. PMID: 21070583; PMCID: PMC3292346.
    66. Taxel P, Dowsett R, Richter L, Fall P, Klepinger A, Albertsen P. Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer. BJU Int. 2010 Nov; 106(10):1473-6. PMID: 20456336.
      View in: PubMed
    67. Albertsen P. Further support for active surveillance in the management of low-volume, low-grade prostate cancer. Eur Urol. 2010 Dec; 58(6):836-7. PMID: 20851512.
      View in: PubMed
    68. Hamilton AS, Albertsen PC, Johnson TK, Hoffman R, Morrell D, Deapen D, Penson DF. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int. 2011 Feb; 107(4):576-84. PMID: 20735387.
      View in: PubMed
    69. Shao YH, Albertsen PC, Roberts CB, Lin Y, Mehta AR, Stein MN, DiPaola RS, Lu-Yao GL. Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml. Arch Intern Med. 2010 Jul 26; 170(14):1256-61. PMID: 20660846; PMCID: PMC3651841.
    70. Albertsen PC. Treatment of localized prostate cancer: when is active surveillance appropriate? Nat Rev Clin Oncol. 2010 Jul; 7(7):394-400. PMID: 20440282.
      View in: PubMed
    71. Stokes ME, Black L, Benedict A, Roehrborn CG, Albertsen P. Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data. Prostate Cancer Prostatic Dis. 2010 Sep; 13(3):278-84. PMID: 20212521.
      View in: PubMed
    72. Albertsen PC. Editorial comment. J Urol. 2010 Apr; 183(4):1509. PMID: 20172560.
      View in: PubMed
    73. Albertsen PC. Efficacy vs effectiveness in prostate-specific antigen screening. J Natl Cancer Inst. 2010 Mar 3; 102(5):288-9. PMID: 20142583.
      View in: PubMed
    74. Albertsen PC. Does the benefit justify the risk? J Natl Cancer Inst. 2010 Jan 6; 102(1):4-5. PMID: 19996059.
      View in: PubMed
    75. Albertsen PC. The unintended burden of increased prostate cancer detection associated with prostate cancer screening and diagnosis. Urology. 2010 Feb; 75(2):399-405. PMID: 19931892.
      View in: PubMed
    76. Albertsen P. Regionalizing urologic cancer care: appropriate health care policy? Urol Oncol. 2010 Jan-Feb; 28(1):1-3. PMID: 19914108.
      View in: PubMed
    77. Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P. Prostate specific antigen best practice statement: 2009 update. J Urol. 2009 Nov; 182(5):2232-41. PMID: 19781717.
      View in: PubMed
    78. Bailey DE, Wallace M, Latini DM, Hegarty J, Carroll PR, Klein EA, Albertsen PC. Measuring illness uncertainty in men undergoing active surveillance for prostate cancer. Appl Nurs Res. 2011 Nov; 24(4):193-9. PMID: 20974073; PMCID: PMC3070758.
    79. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O'Leary M, Walker-Corkery E, Yao SL. Outcomes of localized prostate cancer following conservative management. JAMA. 2009 Sep 16; 302(11):1202-9. PMID: 19755699; PMCID: PMC2822438.
    80. Delbanco T, Albertsen PC. A 72-year-old man with localized prostate cancer--14 years later. JAMA. 2009 Sep 9; 302(10):1105-6. PMID: 19738095.
      View in: PubMed
    81. Albertsen PC. An iatrogenic confounding variable. J Natl Cancer Inst. 2009 Oct 21; 101(20):1368-9. PMID: 19741210.
      View in: PubMed
    82. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst. 2009 Oct 7; 101(19):1325-9. PMID: 19720969; PMCID: PMC2758309.
    83. Albertsen P. Lies, damn lies, and cancer statistics. Eur Urol. 2009 Oct; 56(4):592-3. PMID: 19656616.
      View in: PubMed
    84. Albertsen P. Androgen deprivation in prostate cancer--step by step. N Engl J Med. 2009 Jun 11; 360(24):2572-4. PMID: 19516038.
      View in: PubMed
    85. Roehrborn CG, Albertsen P, Stokes ME, Black L, Benedict A. First-year costs of treating prostate cancer: estimates from SEER-Medicare data. Prostate Cancer Prostatic Dis. 2009; 12(4):355-60. PMID: 19468284.
      View in: PubMed
    86. Donovan MJ, Khan FM, Fernandez G, Mesa-Tejada R, Sapir M, Zubek VB, Powell D, Fogarasi S, Vengrenyuk Y, Teverovskiy M, Segal MR, Karnes RJ, Gaffey TA, Busch C, Haggman M, Hlavcak P, Freedland SJ, Vollmer RT, Albertsen P, Costa J, Cordon-Cardo C. Personalized prediction of tumor response and cancer progression on prostate needle biopsy. J Urol. 2009 Jul; 182(1):125-32. PMID: 19450827.
      View in: PubMed
    87. Bellera CA, Hanley JA, Joseph L, Albertsen PC. A statistical evaluation of rules for biochemical failure after radiotherapy in men treated for prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Dec 1; 75(5):1357-63. PMID: 19395198.
      View in: PubMed
    88. Albertsen P. Words of wisdom. Re: Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial. Eur Urol. 2009 Apr; 55(4):989-90. PMID: 19650212.
      View in: PubMed
    89. Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, Blot WJ, Carter HB, Costantino JP, Epstein JI, Godley PA, Harris RP, Wilt TJ, Wittes J, Zon R, Schellhammer P. Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. J Urol. 2009 Apr; 181(4):1642-57. PMID: 19249063.
      View in: PubMed
    90. Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, Blot WJ, Ballentine Carter H, Costantino JP, Epstein JI, Godley PA, Harris RP, Wilt TJ, Wittes J, Zon R, Schellhammer P. Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. J Clin Oncol. 2009 Mar 20; 27(9):1502-16. PMID: 19252137; PMCID: PMC2668556.
    91. Lu-Yao G, Albertsen P, Shih W, Yao SL. Failure to report financial disclosure information. JAMA. 2009 Jan 7; 301(1):35-6. PMID: 19126808.
      View in: PubMed
    92. Albertsen PC. A challenge to contemporary management of prostate cancer. Nat Clin Pract Urol. 2009 Jan; 6(1):12-3. PMID: 19065140.
      View in: PubMed
    93. Albertsen PC. The treatment paradigm shifts again on prostate cancer. Eur Urol. 2009 Jan; 55(1):9-11; discussion 11-3. PMID: 18819745.
      View in: PubMed
    94. Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery E, Barry MJ. Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up. J Gen Intern Med. 2008 Nov; 23(11):1809-14. PMID: 18795372; PMCID: PMC2585661.
    95. Kakizoe T, Mucci LA, Albertsen PC, Droller MJ. Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease. Scand J Urol Nephrol Suppl. 2008 Sep; (218):191-212. PMID: 18815934.
      View in: PubMed
    96. Ercole B, Marietti SR, Fine J, Albertsen PC. Outcomes following active surveillance of men with localized prostate cancer diagnosed in the prostate specific antigen era. J Urol. 2008 Oct; 180(4):1336-9; discussion 1340-1. PMID: 18707696.
      View in: PubMed
    97. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Yao SL. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA. 2008 Jul 9; 300(2):173-81. PMID: 18612114; PMCID: PMC2645653.
    98. Albertsen P. Should patients consider active surveillance? Cancer. 2008 Jun 15; 112(12):2631-4. PMID: 18429003.
      View in: PubMed
    99. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol. 2008 May; 179(5 Suppl):S40-4. PMID: 18405749.
      View in: PubMed
    100. Collin SM, Martin RM, Metcalfe C, Gunnell D, Albertsen PC, Neal D, Hamdy F, Stephens P, Lane JA, Moore R, Donovan J. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol. 2008 May; 9(5):445-52. PMID: 18424233; PMCID: PMC2760747.
    101. Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Wallace ME, Kantoff PW, Carroll PR. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer. 2008 Apr 15; 112(8):1650-9. PMID: 18306379.
      View in: PubMed
    102. Albertsen PC. The face of high risk prostate cancer. World J Urol. 2008 Jun; 26(3):205-10. PMID: 18401585.
      View in: PubMed
    103. Bellera CA, Hanley JA, Joseph L, Albertsen PC. Hierarchical changepoint models for biochemical markers illustrated by tracking postradiotherapy prostate-specific antigen series in men with prostate cancer. Ann Epidemiol. 2008 Apr; 18(4):270-82. PMID: 18374279.
      View in: PubMed
    104. Albertsen PC. Should men over the age of 65 years receive PSA screening? Argument against. Nat Clin Pract Urol. 2008 May; 5(5):232-3. PMID: 18349860.
      View in: PubMed
    105. Bellera CA, Hanley JA, Joseph L, Albertsen PC. Detecting trends in noisy data series: application to biomarker series. Am J Epidemiol. 2008 May 1; 167(9):1130-9. PMID: 18303004.
      View in: PubMed
    106. Hussain S, Gunnell D, Donovan J, McPhail S, Hamdy F, Neal D, Albertsen P, Verne J, Stephens P, Trotter C, Martin RM. Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004. BJU Int. 2008 Mar; 101(5):547-55. PMID: 18190630; PMCID: PMC2765909.
    107. Albertsen P. Predicting survival for men with clinically localized prostate cancer: what do we need in contemporary practice? Cancer. 2008 Jan 1; 112(1):1-3. PMID: 18000802.
      View in: PubMed
    108. Albertsen P. Should men with low-risk, localized prostate cancer choose active surveillance or undergo a robotic prostatectomy? Curr Urol Rep. 2008 Jan; 9(1):1-2. PMID: 18366966.
      View in: PubMed
    109. Seidenfeld J, Samson DJ, Albertsen PC. Competing risks for patients with localized prostate cancer. J Natl Cancer Inst. 2007 Oct 17; 99(20):1498-9. PMID: 17925533.
      View in: PubMed
    110. Judge A, Evans S, Gunnell DJ, Albertsen PC, Verne J, Martin RM. Patient outcomes and length of hospital stay after radical prostatectomy for prostate cancer: analysis of hospital episodes statistics for England. BJU Int. 2007 Nov; 100(5):1040-9. PMID: 17784890.
      View in: PubMed
    111. Lu-Yao GL, Barry MJ, Albertsen PC, Yao SL. Outcomes of treatment vs observation of localized prostate cancer in elderly men. JAMA. 2007 Apr 18; 297(15):1651; author reply 1652-3. PMID: 17440140.
      View in: PubMed
    112. Albertsen P. What do we really know about prostate cancer? Eur Urol. 2007 Oct; 52(4):948-50. PMID: 17442481.
      View in: PubMed
    113. Albertsen PC. Commentary: occult prostate cancer--imposter or the real deal? Int J Epidemiol. 2007 Apr; 36(2):281-2. PMID: 17567643.
      View in: PubMed
    114. Albertsen PC, Hanley JA, Penson DF, Barrows G, Fine J. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J Urol. 2007 Mar; 177(3):932-6. PMID: 17296379.
      View in: PubMed
    115. Albertsen PC. Does radical prostatectomy provide a survival benefit as primary treatment for high-grade prostate cancer? Nat Clin Pract Urol. 2007 Feb; 4(2):68-9. PMID: 17228312.
      View in: PubMed
    116. Albertsen PC. PSA and the conservative treatment of early prostate cancer. Arch Ital Urol Androl. 2006 Dec; 78(4):152-3. PMID: 17269621.
      View in: PubMed
    117. Albertsen PC. PSA testing: public policy or private penchant? JAMA. 2006 Nov 15; 296(19):2371-3. PMID: 17105802.
      View in: PubMed
    118. Schröder FH, Albertsen P. Open to debate. The motion: there is evidence that prostate cancer screening does more good than harm. Eur Urol. 2006 Aug; 50(2):377-80. PMID: 16762483.
      View in: PubMed
    119. Bellera CA, Hanley JA, Joseph L, Albertsen PC. A charting tool for estimating the PSA doubling time in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Sep 1; 66(1):315-6. PMID: 16820269.
      View in: PubMed
    120. Albertsen PC. The changing nature of women's sexual health concerns through the midlife years. J Urol. 2005 Nov; 174(5):1969. PMID: 16217370.
      View in: PubMed
    121. Albertsen PC. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy. J Urol. 2005 Nov; 174(5):1969-70. PMID: 16217368.
      View in: PubMed
    122. Albertsen PC. What is the value of screening for prostate cancer in the US? Nat Clin Pract Oncol. 2005 Nov; 2(11):536-7. PMID: 16270077.
      View in: PubMed
    123. Albertsen PC. Facing erectile dysfunction due to prostate cancer treatment: perspectives of men and their partners. J Urol. 2005 Nov; 174(5):1969. PMID: 16217369.
      View in: PubMed
    124. Albertsen PC. Antibiotics on urethral catheter withdrawal: a hit and miss affair. J Urol. 2005 Oct; 174(4 Pt 1):1399. PMID: 16145447.
      View in: PubMed
    125. Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PD, Sanders MM, Fine J. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst. 2005 Sep 7; 97(17):1248-53. PMID: 16145045.
      View in: PubMed
    126. Albertsen PC. Minimally invasive therapy for renal cell carcinoma: is there a new community standard? J Urol. 2005 Sep; 174(3):869. PMID: 16093976.
      View in: PubMed
    127. Albertsen PC. General versus spinal anesthesia in patients undergoing radical retropubic prostatectomy: results of a prospective, randomized study. J Urol. 2005 Sep; 174(3):931. PMID: 16093995.
      View in: PubMed
    128. Albertsen PC. The prevalence of urinary incontinence in community-dwelling married women: a matter of definition. J Urol. 2005 Aug; 174(2):613. PMID: 16006921.
      View in: PubMed
    129. Albertsen PC. Epidemiology of incontinence and prolapse. J Urol. 2005 Aug; 174(2):613. PMID: 16006922.
      View in: PubMed
    130. Albertsen PC. Healthcare use and costs of primary and secondary care patients with prostatitis. J Urol. 2005 Jun; 173(6):2104. PMID: 15879852.
      View in: PubMed
    131. Albertsen PC. Prostate-specific antigen: how to advise patients as the screening debate continues. Cleve Clin J Med. 2005 Jun; 72(6):521-7. PMID: 16018293.
      View in: PubMed
    132. Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005 May 4; 293(17):2095-101. PMID: 15870412.
      View in: PubMed
    133. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol. 2005 May; 173(5):1701-5. PMID: 15821561.
      View in: PubMed
    134. Albertsen PC. Variation in Urological Practice Amongst Spinal Injuries Units in the UK and Eire. J Urol. 2005 Apr; 173(4):1327-8. PMID: 15758791.
      View in: PubMed
    135. Albertsen PC. The economic impact of chronic prostatitis. J Urol. 2005 Apr; 173(4):1327. PMID: 15758792.
      View in: PubMed
    136. Albertsen PC. Development and Validation of the Self-Esteem and Relationship (SEAR) Questionnaire in Erectile Dysfunction. J Urol. 2005 Apr; 173(4):1328. PMID: 15758793.
      View in: PubMed
    137. Albertsen PC. Single-blind, randomized trial of pelvic floor muscle training, biofeedback-assisted pelvic floor muscle training, and electrical stimulation in the management of overactive bladder. J Urol. 2005 Mar; 173(3):942. PMID: 15711345.
      View in: PubMed
    138. Albertsen PC. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. J Urol. 2005 Mar; 173(3):942-3. PMID: 15711344.
      View in: PubMed
    139. Albertsen PC. Is screening for prostate cancer with prostate specific antigen an appropriate public health measure? Acta Oncol. 2005; 44(3):255-64. PMID: 16076698.
      View in: PubMed
    140. Johnson TK, Gilliland FD, Hoffman RM, Deapen D, Penson DF, Stanford JL, Albertsen PC, Hamilton AS. Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. J Clin Oncol. 2004 Oct 15; 22(20):4193-201. PMID: 15483030.
      View in: PubMed
    141. Taylor JA, Kao TC, Albertsen PC, Shabsigh R. Bicycle riding and its relationship to the development of erectile dysfunction. J Urol. 2004 Sep; 172(3):1028-31. PMID: 15311030.
      View in: PubMed
    142. Albertsen PC, Hanley JA, Penson DF, Fine J. Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation. J Urol. 2004 Jun; 171(6 Pt 1):2221-5. PMID: 15126789.
      View in: PubMed
    143. Hsieh K, Albertsen PC. Populations at high risk for prostate cancer. Urol Clin North Am. 2003 Nov; 30(4):669-76. PMID: 14680306.
      View in: PubMed
    144. Hsieh K, Taylor JA, Albertsen PC. Lower urinary tract symptoms in the older male. Conn Med. 2003 Sep; 67(8):487-90. PMID: 14587129.
      View in: PubMed
    145. Albertsen PC. Unexplained extra visits to general practitioners before the diagnosis of first urinary tract infection: a case-control study. J Urol. 2003 Aug; 170(2 Pt 1):696-7. PMID: 14601613.
      View in: PubMed
    146. Albertsen PC. Risk factors for recurrent urinary tract infection in young women. J Urol. 2003 Aug; 170(2 Pt 1):698. PMID: 14601615.
      View in: PubMed
    147. Albertsen PC. Medium-term follow-up of transvaginal suburethral slings: variance in outcome success using two different evaluation methods. J Urol. 2003 Aug; 170(2 Pt 1):698. PMID: 14601616.
      View in: PubMed
    148. Albertsen PC. The use of models in the estimation of disease epidemiology. J Urol. 2003 Aug; 170(2 Pt 1):697. PMID: 14601614.
      View in: PubMed
    149. Zeliadt SB, Penson DF, Albertsen PC, Concato J, Etzioni RD. Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis. Cancer. 2003 Aug 1; 98(3):496-503. PMID: 12879465.
      View in: PubMed
    150. Albertsen PC. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region. J Urol. 2003 Aug; 170(2 Pt 1):696. PMID: 14601612.
      View in: PubMed
    151. Albertsen PC. The prostate cancer conundrum. J Natl Cancer Inst. 2003 Jul 2; 95(13):930-1. PMID: 12837821.
      View in: PubMed
    152. Chakraborty NG, Stevens RL, Mehrotra S, Laska E, Taxel P, Sporn JR, Schauer P, Albertsen PC. Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation. Cancer Immunol Immunother. 2003 Aug; 52(8):497-505. PMID: 12783216.
      View in: PubMed
    153. Kessler B, Albertsen P. The natural history of prostate cancer. Urol Clin North Am. 2003 May; 30(2):219-26. PMID: 12735499.
      View in: PubMed
    154. Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, Deapen D, Gilliland F, Hoffman R, Stephenson RA, Potosky AL, Stanford JL. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol. 2003 Mar 15; 21(6):1147-54. PMID: 12637483.
      View in: PubMed
    155. Taxel P, Fall PM, Albertsen PC, Dowsett RD, Trahiotis M, Zimmerman J, Ohannessian C, Raisz LG. The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer. J Clin Endocrinol Metab. 2002 Nov; 87(11):4907-13. PMID: 12414849.
      View in: PubMed
    156. Albertsen PC. The conundrum of prostate cancer. Cancer J. 2002 Nov-Dec; 8(6):432-4. PMID: 12500849.
      View in: PubMed
    157. Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ. 2002 Oct 5; 325(7367):740. PMID: 12364300; PMCID: PMC128373.
    158. McNaughton Collins M, Barry MJ, Zietman A, Albertsen PC, Talcott JA, Walker Corkery E, Elliott DB, Fowler FJ. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region. Urology. 2002 Oct; 60(4):628-33. PMID: 12385923.
      View in: PubMed
    159. Albertsen PC. Survey of voiding dysfunction and urinary retention after anti-incontinence procedures. J Urol. 2002 Aug; 168(2):882-3. PMID: 12136875.
      View in: PubMed
    160. Albertsen PC. Guided medication dosing for inpatients with renal insufficiency. J Urol. 2002 Aug; 168(2):879-80. PMID: 12136871.
      View in: PubMed
    161. Albertsen PC. Needs assessment of women with urinary incontinence in a district health authority. J Urol. 2002 Aug; 168(2):880. PMID: 12136872.
      View in: PubMed
    162. Albertsen PC. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. J Urol. 2002 Aug; 168(2):880-1. PMID: 12136873.
      View in: PubMed
    163. Albertsen PC. Estimating a population's needs for the treatment of lower urinary tract symptoms in men: what is the extent of unmet need? J Urol. 2002 Aug; 168(2):878-9. PMID: 12136870.
      View in: PubMed
    164. Albertsen PC. Decline in bilateral orchiectomy for prostate cancer in Olmsted County, Minnesota, 1956-2000. J Urol. 2002 Aug; 168(2):878. PMID: 12136869.
      View in: PubMed
    165. Albertsen PC. An experimental inter-expert telepathology network using static imaging. J Urol. 2002 Aug; 168(2):877-8. PMID: 12136868.
      View in: PubMed
    166. Albertsen PC. A psychometric analysis of the measurement level of the rating scale, time trade-off, and standard gamble. J Urol. 2002 Aug; 168(2):881-2. PMID: 12136874.
      View in: PubMed
    167. Samson DJ, Seidenfeld J, Schmitt B, Hasselblad V, Albertsen PC, Bennett CL, Wilt TJ, Aronson N. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer. 2002 Jul 15; 95(2):361-76. PMID: 12124837.
      View in: PubMed
    168. Penson DF, Albertsen PC. Lessons learnt about early prostate cancer from large scale databases: population-based pearls of wisdom. Surg Oncol. 2002 Jun; 11(1-2):3-11. PMID: 12031863.
      View in: PubMed
    169. Schwartz E, Albertsen P. Nomograms for clinically localized disease. Part III: watchful waiting. Semin Urol Oncol. 2002 May; 20(2):140-5. PMID: 12012300.
      View in: PubMed
    170. Collins S, Upshaw J, Rutchik S, Ohannessian C, Ortenberg J, Albertsen P. Effects of circumcision on male sexual function: debunking a myth? J Urol. 2002 May; 167(5):2111-2. PMID: 11956452.
      View in: PubMed
    171. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, Kreutzer DL. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology. 2002 Apr; 59(4):603-8. PMID: 11927336.
      View in: PubMed
    172. Potosky AL, Reeve BB, Clegg LX, Hoffman RM, Stephenson RA, Albertsen PC, Gilliland FD, Stanford JL. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst. 2002 Mar 20; 94(6):430-7. PMID: 11904315.
      View in: PubMed
    173. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, Kreutzer DL. Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol. 2002 Feb; 167(2 Pt 1):753-6. PMID: 11792966.
      View in: PubMed
    174. Albertsen PC. Which results justify the means in prostate cancer treatment? Cancer J. 2002 Jan-Feb; 8(1):30-2. PMID: 11895201.
      View in: PubMed
    175. Harlan LC, Potosky A, Gilliland FD, Hoffman R, Albertsen PC, Hamilton AS, Eley JW, Stanford JL, Stephenson RA. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst. 2001 Dec 19; 93(24):1864-71. PMID: 11752011.
      View in: PubMed
    176. Penson DF, Albertsen PC, Nelson PS, Barry M, Stanford JL. Determining cause of death in prostate cancer: are death certificates valid? J Natl Cancer Inst. 2001 Dec 5; 93(23):1822-3. PMID: 11734600.
      View in: PubMed
    177. Potosky AL, Knopf K, Clegg LX, Albertsen PC, Stanford JL, Hamilton AS, Gilliland FD, Eley JW, Stephenson RA, Hoffman RM. Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol. 2001 Sep 1; 19(17):3750-7. PMID: 11533098.
      View in: PubMed
    178. Barry MJ, Albertsen PC, Bagshaw MA, Blute ML, Cox R, Middleton RG, Gleason DF, Zincke H, Bergstralh EJ, Jacobsen SJ. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer. 2001 Jun 15; 91(12):2302-14. PMID: 11413519.
      View in: PubMed
    179. Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Hoffman RM, Eley JW, Harlan LC, Potosky AL. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J Clin Oncol. 2001 May 1; 19(9):2517-26. PMID: 11331331.
      View in: PubMed
    180. Sneeuw KC, Albertsen PC, Aaronson NK. Comparison of patient and spouse assessments of health related quality of life in men with metastatic prostate cancer. J Urol. 2001 Feb; 165(2):478-82. PMID: 11176400.
      View in: PubMed
    181. Albertsen PC, Albertsen PC. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. J Urol. 2001 Feb; 165(2):731-2. PMID: 11233050.
      View in: PubMed
    182. D'Alessandri RM, Albertsen P, Atkinson BF, Dickler RM, Jones RF, Kirch DG, Longnecker DE, McAnarney ER, Parisi VM, Selby SE, Stapczynski JS, Thompson JW, Wasserman AG, Zuza KL. Measuring contributions to the clinical mission of medical schools and teaching hospitals. Acad Med. 2000 Dec; 75(12):1231-7. PMID: 11112730.
      View in: PubMed
    183. Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 2000 Oct 4; 92(19):1582-92. PMID: 11018094.
      View in: PubMed
    184. Gomella LG, Albertsen PC, Benson MC, Forman JD, Soloway MS. The use of video-based patient education for shared decision-making in the treatment of prostate cancer. Semin Urol Oncol. 2000 Aug; 18(3):182-7. PMID: 10975489.
      View in: PubMed
    185. Fowler FJ, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA. 2000 Jun 28; 283(24):3217-22. PMID: 10866869.
      View in: PubMed
    186. Albertsen P. When is a death from prostate cancer not a death from prostate cancer? J Natl Cancer Inst. 2000 Apr 19; 92(8):590-1. PMID: 10772664.
      View in: PubMed
    187. Seidenfeld J, Samson DJ, Hasselblad V, Aronson N, Albertsen PC, Bennett CL, Wilt TJ. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med. 2000 Apr 4; 132(7):566-77. PMID: 10744594.
      View in: PubMed
    188. Albertsen PC, Hanley JA, Harlan LC, Gilliland FD, Hamilton A, Liff JM, Stanford JL, Stephenson RA. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. J Urol. 2000 Apr; 163(4):1138-43. PMID: 10737483.
      View in: PubMed
    189. McNaughton Collins M, Fowler FJ, Elliott DB, Albertsen PC, Barry MJ. Diagnosing and treating chronic prostatitis: do urologists use the four-glass test? Urology. 2000 Mar; 55(3):403-7. PMID: 10699621.
      View in: PubMed
    190. Albertsen PC, Walters S, Hanley JA. A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol. 2000 Feb; 163(2):519-23. PMID: 10647669.
      View in: PubMed
    191. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW, Albertsen PC, Harlan LC, Potosky AL. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA. 2000 Jan 19; 283(3):354-60. PMID: 10647798.
      View in: PubMed
    192. Potosky AL, Harlan LC, Stanford JL, Gilliland FD, Hamilton AS, Albertsen PC, Eley JW, Liff JM, Deapen D, Stephenson RA, Legler J, Ferrans CE, Talcott JA, Litwin MS. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 1999 Oct 20; 91(20):1719-24. PMID: 10528021.
      View in: PubMed
    193. Gilliland FD, Hoffman RM, Hamilton A, Albertsen P, Eley JW, Harlan L, Stanford JL, Hunt WC, Potosky A, Stephenson RA. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J Urol. 1999 Oct; 162(4):1341-5. PMID: 10492193.
      View in: PubMed
    194. Ferrer FA, Miller LJ, Lindquist R, Kowalczyk P, Laudone VP, Albertsen PC, Kreutzer DL. Expression of vascular endothelial growth factor receptors in human prostate cancer. Urology. 1999 Sep; 54(3):567-72. PMID: 10475375.
      View in: PubMed
    195. Albertsen PC, Hanley JA, Murphy-Setzko M. Statistical considerations when assessing outcomes following treatment for prostate cancer. J Urol. 1999 Aug; 162(2):439-44. PMID: 10411053.
      View in: PubMed
    196. Lu-Yao GL, Albertsen P, Warren J, Yao SL. Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy--a population-based study. Urology. 1999 Aug; 54(2):301-7. PMID: 10443729.
      View in: PubMed
    197. Albertsen PC, Pellissier JM, Lowe FC, Girman CJ, Roehrborn CG. Economic analysis of finasteride: a model-based approach using data from the Proscar Long-Term Efficacy and Safety Study. Clin Ther. 1999 Jun; 21(6):1006-24. PMID: 10440624.
      View in: PubMed
    198. Albertsen PC. Re: Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. J Natl Cancer Inst. 1999 Apr 7; 91(7):646. PMID: 10203286.
      View in: PubMed
    199. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, Agertoft L, Djernes B, Nathan E, Reinholdt J. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics. 1999 Feb; 103(2):E24. PMID: 9925870.
      View in: PubMed
    200. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA. 1998 Sep 16; 280(11):975-80. PMID: 9749479.
      View in: PubMed
    201. Richman AM, Mayne ST, Jekel JF, Albertsen P. Image analysis combined with visual cytology in the early detection of recurrent bladder carcinoma. Cancer. 1998 May 1; 82(9):1738-48. PMID: 9576297.
      View in: PubMed
    202. Albertsen PC. Computer modeling--what should we look for? J Urol. 1998 Mar; 159(3):934. PMID: 9474186.
      View in: PubMed
    203. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, Albertsen P, Roehrborn CG, Nickel JC, Wang DZ, Taylor AM, Waldstreicher J. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998 Feb 26; 338(9):557-63. PMID: 9475762.
      View in: PubMed
    204. Gee WF, Holtgrewe HL, Albertsen PC, Cooper TP, Fenninger RB, Litwin MS, Manyak MJ, Meyer JJ, Miles BJ, O'Leary MP, Painter MR, Rohner TJ, Thomas R, Blizzard RT, Emmons L. Subspecialization, recruitment and retirement trends of American urologists. J Urol. 1998 Feb; 159(2):509-11. PMID: 9649278.
      View in: PubMed
    205. Albertsen PC, Nease RF, Potosky AL. Assessment of patient preferences among men with prostate cancer. J Urol. 1998 Jan; 159(1):158-63. PMID: 9400461.
      View in: PubMed
    206. Onel E, Hamond C, Wasson JH, Berlin BB, Ely MG, Laudone VP, Tarantino AE, Albertsen PC. Assessment of the feasibility and impact of shared decision making in prostate cancer. Urology. 1998 Jan; 51(1):63-6. PMID: 9457290.
      View in: PubMed
    207. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology. 1998 Jan; 51(1):161-7. PMID: 9457313.
      View in: PubMed
    208. Albertsen PC. Prostate disease in older men: 2. Cancer. Hosp Pract (1995). 1997 Oct 15; 32(10):159-66, 171, 175-6 passim. PMID: 9341640.
      View in: PubMed
    209. Albertsen PC. Urology. JAMA. 1997 Jun 18; 277(23):1904-5. PMID: 9185828.
      View in: PubMed
    210. Albertsen P. Unraveling the epidemiology of prostate cancer. J Urol. 1997 Jun; 157(6):2223-4. PMID: 9146620.
      View in: PubMed
    211. Ferrer FA, Miller LJ, Andrawis RI, Kurtzman SH, Albertsen PC, Laudone VP, Kreutzer DL. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells. J Urol. 1997 Jun; 157(6):2329-33. PMID: 9146665.
      View in: PubMed
    212. Albertsen PC. Prostate disease in older men: 1. Benign hyperplasia. Hosp Pract (1995). 1997 May 15; 32(5):61-4, 67-8, 77 passim. PMID: 9153140.
      View in: PubMed
    213. Albertsen PC, Aaronson NK, Muller MJ, Keller SD, Ware JE. Health-related quality of life among patients with metastatic prostate cancer. Urology. 1997 Feb; 49(2):207-16; discussion 216-7. PMID: 9037282.
      View in: PubMed
    214. Albertsen PC. Urologic 'nuisances': how to work up and relieve men's symptoms. Geriatrics. 1997 Feb; 52(2):46-50, 53-4; quiz 55. PMID: 9053386.
      View in: PubMed
    215. Fryback DG, Albertsen PC, Storer BE. Prostatectomy and survival among men with clinically localized prostate cancer. JAMA. 1996 Dec 4; 276(21):1723-4; author reply 1724. PMID: 8940318.
      View in: PubMed
    216. Welch HG, Albertsen PC, Wasson JH. Assessing competing risks in treating the elderly. Hosp Pract (1995). 1996 Nov 15; 31(11):155-6, 158-9, 162, passim. PMID: 8941165.
      View in: PubMed
    217. Albertsen PC. Screening for prostate cancer is neither appropriate nor cost-effective. Urol Clin North Am. 1996 Nov; 23(4):521-30. PMID: 8948407.
      View in: PubMed
    218. Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O'Leary MP, Painter MR, Blizzard RT, Fenninger RB, Emmons L. Practice trends of American urologists in the treatment of impotence, incontinence and infertility. J Urol. 1996 Nov; 156(5):1778-80. PMID: 8863607.
      View in: PubMed
    219. Albertsen PC. Defining clinically significant prostate cancer: pathologic criteria versus outcomes data. J Natl Cancer Inst. 1996 Sep 4; 88(17):1177-8. PMID: 8780622.
      View in: PubMed
    220. Albertsen PC. African-Americans and prostate cancer. Cancer J Sci Am. 1996 Jul-Aug; 2(4):200-1. PMID: 9166531.
      View in: PubMed
    221. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol. 1996 Jul; 156(1):127-32. PMID: 8648773.
      View in: PubMed
    222. Albertsen PC. Urology. JAMA. 1996 Jun 19; 275(23):1857-8. PMID: 8642751.
      View in: PubMed
    223. Albertsen PC. Early-stage prostate cancer. When is observation appropriate? Hematol Oncol Clin North Am. 1996 Jun; 10(3):611-25. PMID: 8773500.
      View in: PubMed
    224. Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med. 1996 Mar 15; 124(6):577-84. PMID: 8597322.
      View in: PubMed
    225. Lu-Yao GL, Potosky AL, Albertsen PC, Wasson JH, Barry MJ, Wennberg JE. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Cancer Inst. 1996 Feb 21; 88(3-4):166-73. PMID: 8632490.
      View in: PubMed
    226. Mulhall JP, Albertsen PC. Hemospermia: diagnosis and management. Urology. 1995 Oct; 46(4):463-7. PMID: 7571212.
      View in: PubMed
    227. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA. 1995 Aug 23-30; 274(8):626-31. PMID: 7637143.
      View in: PubMed
    228. Albertsen P. A 72-year-old man with localized prostate cancer. JAMA. 1995 Jul 5; 274(1):69-74. PMID: 7791261.
      View in: PubMed
    229. Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O'Leary MP, Painter MR. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. J Urol. 1995 Jul; 154(1):205-6. PMID: 7539861.
      View in: PubMed
    230. Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O'Leary MP, Painter MR. Practice trends in the diagnosis and management of prostate cancer in the United States. J Urol. 1995 Jul; 154(1):207-8. PMID: 7539862.
      View in: PubMed
    231. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995 Feb 15; 273(7):548-52. PMID: 7530782.
      View in: PubMed
    232. Albertsen P, Fine J. Prostate biopsy in the community: who are the most likely candidates? Contemp Urol. 1995 Feb; 7(2):54-7. PMID: 10150177.
      View in: PubMed
    233. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrøm K, Jacobsen T. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med. 1994 Oct 20; 331(16):1051-5. PMID: 8090164.
      View in: PubMed
    234. Cromley EK, Albertsen PC. Multiple-site physician practices and their effect on service distribution. Health Serv Res. 1993 Oct; 28(4):503-22. PMID: 8407340; PMCID: PMC1069954.
    235. Albertsen PC, Fine J. Building population data bases: lessons from a community project. Clin Perform Qual Health Care. 1993 Oct-Dec; 1(4):191-3. PMID: 10135633.
      View in: PubMed
    236. Albertsen PC. Computer modeling and decision making: clinical applications in bladder cancer. Semin Urol. 1993 Aug; 11(3):171-6. PMID: 8210838.
      View in: PubMed
    237. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA. 1993 May 26; 269(20):2650-8. PMID: 8487449.
      View in: PubMed
    238. Moltesen B, Albertsen P, Viskum K, Peitersen B. [Congenital tuberculosis. 2 case reports]. Ugeskr Laeger. 1992 Sep 7; 154(37):2503-5. PMID: 1413177.
      View in: PubMed
    239. Verder H, Agertoft L, Albertsen P, Christensen NC, Curstedt T, Ebbesen F, Greisen G, Hobolth N, Holm V, Jacobsen T, et al. [Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study]. Ugeskr Laeger. 1992 Jul 27; 154(31):2136-9. PMID: 1509593.
      View in: PubMed
    240. Small JD, Albertsen PC, Graydon RJ, Ricci A, Sardella WV. Adenoid cystic carcinoma of Cowper's gland. J Urol. 1992 Mar; 147(3):699-701. PMID: 1311394.
      View in: PubMed
    241. Albertsen PC, Kamens EA. Variations in coding practices among Connecticut urologists for the Medicare population. Conn Med. 1990 Sep; 54(9):508-11. PMID: 2225818.
      View in: PubMed
    242. Albertsen P, Petersen S, Pilgaard B, Tranebjaerg L, Hancke S, Krasilnikoff PA. [Abdominal symptoms as the first sign in Schönlein-Henoch syndrome]. Ugeskr Laeger. 1988 Oct 17; 150(42):2531-3. PMID: 3061110.
      View in: PubMed
    243. Gearhart JP, Albertsen PC, Marshall FF, Jeffs RD. Pediatric applications of augmentation cystoplasty: the Johns Hopkins experience. J Urol. 1986 Aug; 136(2):430-2. PMID: 3735510.
      View in: PubMed
    244. Oesterling JE, Bromberg WD, Albertsen PC. Xeroradiography and ultrasonography in the evaluation of a penile injury. J Urol. 1986 Apr; 135(4):791-3. PMID: 3514963.
      View in: PubMed
    245. Brendler CB, Albertsen PC, Goldman SM, Hill GS, Lowe FC, Millan JC. Acquired renal cystic disease in the end stage kidney: urological implications. J Urol. 1984 Sep; 132(3):548-52. PMID: 6471194.
      View in: PubMed
    246. Albertsen PC, Albertsen PS. Evaluation of a new nonadhesive urine collection device for patients with ileal conduits. J Urol. 1984 Mar; 131(3):454-5. PMID: 6699984.
      View in: PubMed
    247. Nadel SN, Hutchins GM, Albertsen PC, White RI. Valves of the internal spermatic vein: potential for misdiagnosis of varicocele by venography. Fertil Steril. 1984 Mar; 41(3):479-81. PMID: 6698242.
      View in: PubMed
    248. Albertsen PC, Chang TS, Vindivich D, Robinson JC, Smyth JW. A critical method of evaluating tests for male infertility. J Urol. 1983 Sep; 130(3):467-75. PMID: 6688444.
      View in: PubMed
    249. Albertsen P, Marshall F. Optimal management of prostatic cancer. Geriatrics. 1982 Dec; 37(12):69-72, 77-9. PMID: 7141229.
      View in: PubMed
    250. Albertsen P. Histologic grading and the practicing urologist. Prostate. 1982; 3(4):333-8. PMID: 7122330.
      View in: PubMed
    251. Rosenberg SN, Albertsen PC, Jones EE, Roberts RS. Complications of labor and delivery following uncomplicated pregnancy. Med Care. 1981 Jan; 19(1):68-79. PMID: 7464312.
      View in: PubMed
    Albertsen's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Physical Neighbors Expand Description
    _